Meridian Bioscience, Inc.
Works in ENT · GI & liver · Infectious disease · Oncology · Respiratory
Meridian Bioscience, Inc. is a clinical trial sponsor. It has no active clinical trials as lead sponsor; its trials since 2021 were across 5 therapeutic areas. Since 2021 it has completed 19 trials and stopped 4 early. Its FDA record on file shows 1 warning letter.
Trial track record · since 2021
FDA record
Recent FDA actions
Pipeline · 0 active trials
No active trials with this company as lead sponsor.
On the market
1 approved drug application with a product on the market.
Questions about Meridian Bioscience, Inc
Yes. FDA has published 1 warning letter naming Meridian Bioscience, Inc; the latest was posted on 2026-01-27. Each letter links to FDA's own posting.
Meridian Bioscience, Inc has no active clinical trials as lead sponsor on ClinicalTrials.gov. Since 2021 it has completed 19 trials and stopped 4 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Meridian Bioscience, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-01-29.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Meridian Bioscience, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.